February 22, 2019
What happened in the base metals space this week? Here's a round up of the top stories covered by the...
December 26, 2016
2016 saw countless pharmaceutical companies taken to task for price gouging. Close to the end of the year, a related...
December 12, 2016
One thing’s clear: if pharmaceutical companies want to remain profitable, they’ll need to tweak their business strategy in 2017.
December 2, 2016
Australian students have successfully produced daraprim, the same drug Martin Shkreli deemed worth $750 a pop.
December 1, 2016
We’re counting down 2016’s five top-performing biotech stocks and exploring possible catalysts for their stock movement.
November 10, 2016
Another surprising upset came out of this election: the defeat of Proposition 61, or California’s Drug Price Relief Act.
November 8, 2016
Proposition 61, which California voters decide on today, has major ramifications for the pharmaceutical industry and its investors.